EGFR and pancreatic neoplasm: Moreover, an activated NRAS/RAF/MEK1/2/ERK/c-Jun axis enhanced the transcription of PD-L1 in melanoma cells52, and induced PD-L1 expression by activating the EGFR/MAPK pathway in pancreatic cancer cells53.